Abstract
HIV infection is incurable, but effective antiretroviral therapy (ART) makes it possible to achieve an undetectable viral load (VL), to preserve the function of the immune system and to prevent the patients health. Due to the constant increase in the use of ART and the high variability of HIV, especially in patients receiving so-called suboptimal therapy for various reasons, the incidence of drug resistance (DR) is increasing. In turn, the presence of DR in an HIV-infected patient affects the effectiveness of therapy, which leads to a limited choice and an increase in the cost of treatment regimens, disease progression and, consequently, an increased risk of death, as well as transmission of infection to partners. The main problems of drug resistance, its types and causes, as well as factors associated with its development are considered. The main drug resistance mutations for each of the drug classes are described.
Publisher
Central Research Institute for Epidemiology
Subject
Infectious Diseases,Virology,General Medicine
Reference67 articles.
1. Federal Scientific and Methodological Center for the Prevention and Control of AIDS. HIV certificate in Russia as of 31.12.2021. Available at: http://www.hivrussia.info/wp-content/uploads/2022/03/Spravka-VICH-v-Rossii-na-31.12.2021-g..pdf (in Russian)
2. WHO. The HIV drug resistance report – 2012. Available at: https://apps.who.int/iris/handle/10665/75183
3. Perera M.R., Wills M.R., Sinclair J.H. HCMV antivirals and strategies to target the latent reservoir. Viruses. 2021; 13(5): 817. https://doi.org/10.3390/v13050817
4. Frange P., Leruez-Ville M. Maribavir, brincidofovir and letermovir: Efficacy and safety of new antiviral drugs for treating cytomegalovirus infections. Med. Mal. Infect. 2018; 48(8): 495–502. https://doi.org/10.1016/j.medmal.2018.03.006
5. Wittkop L., Gunthard H.F., de Wolf F., Dunn D., Cozzi-Lepri A., de Luca A., et al. Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infect. Dis. 2011; 11(5): 363–71. https://doi.org/10.1016/S1473-3099(11)70032-9
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献